Berberis composition for cognitive health
US-2024424045-A1 · Dec 26, 2024 · US
US9168227B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9168227-B2 |
| Application number | US-201314024871-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 12, 2013 |
| Priority date | May 31, 2012 |
| Publication date | Oct 27, 2015 |
| Grant date | Oct 27, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A microsphere and methods for forming the same are disclosed. The microsphere includes modified cellulose and at least one first microsphere disposed within a multi-encapsulating microsphere, the at least one first microsphere comprising at least one first hydrogel precursor; and at least one second microsphere disposed within the multi-encapsulating microsphere, the at least one second microsphere comprising at least one second hydrogel precursor cross-linkable with the at least one first hydrogel precursor upon degradation of the at least one first microsphere and the at least one second microsphere.
Opening claim text (preview).
What is claimed is: 1. A multi-encapsulating microsphere comprising: modified cellulose; at least one first microsphere disposed within the multi-encapsulating microsphere, the at least one first microsphere comprising at least one first hydrogel precursor; and at least one second microsphere disposed within the multi-encapsulating microsphere, the at least one second microsphere comprising at least one second hydrogel precursor cross-linkable with the at least one first hydrogel precursor upon degradation of the at least one first microsphere and the at least one second microsphere. 2. The multi-encapsulating microsphere according to claim 1 , wherein the at least one first hydrogel precursor comprises at least one electrophilic functional group. 3. The multi-encapsulating microsphere according to claim 2 , wherein the at least one electrophilic functional group is selected from the group consisting of N-hydroxysuccinimides, sulfosuccinimides, and combinations thereof. 4. The multi-encapsulating microsphere according to claim 1 , wherein the at least one second hydrogel precursor comprises at least one nucleophilic functional group. 5. The multi-encapsulating microsphere according to claim 4 , wherein the at least one nucleophilic functional group is selected from the group consisting of amines, thiols, and combinations thereof. 6. The multi-encapsulating microsphere according to claim 1 , further comprising: at least one third microsphere disposed within the multi-encapsulating microsphere, the at least one third microsphere encapsulating the at least one second microsphere.
Polyesters, e.g. poly(lactide-co-glycolide) · CPC title
Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs (tablets containing such a mixture A61K9/2077) · CPC title
having two or more different coatings optionally including drug-containing subcoatings · CPC title
Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin (homeopathic globules A61K9/1623) · CPC title
Cellulose; Derivatives thereof · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.